F. W. Henderson, Respiratory-syncytial-virus infections, reinfections and immunity. A prospective, longitudinal study in young children, N Engl J Med, vol.300, issue.10, pp.530-534, 1979.
DOI : 10.1056/nejm197903083001004

D. J. Nokes, Respiratory syncytial virus infection and disease in infants and young children observed from birth in Kilifi District, Clin Infect Dis, vol.46, issue.1, pp.50-57, 2008.
DOI : 10.1086/524019

URL : https://academic.oup.com/cid/article-pdf/46/1/50/967616/46-1-50.pdf

H. Nair, Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and metaanalysis, Lancet, vol.375, issue.9725, pp.1545-55, 2010.

E. E. Walsh, Respiratory syncytial virus infection in adults, Semin Respir Crit Care Med, vol.32, issue.4, pp.423-455, 2011.

E. O. Ohuma, The natural history of respiratory syncytial virus in a birth cohort: the influence of age and previous infection on reinfection and disease, Am J Epidemiol, vol.176, issue.9, pp.794-802, 2012.

M. L. Forbes, Comparative costs of hospitalisation among infants at high risk for respiratory syncytial virus lower respiratory tract infection during the first year of life, J Med Econ, vol.13, issue.1, pp.136-177, 2010.

P. Jacobs, A model of the costs of community and nosocomial pediatric respiratory syncytial virus infections in Canadian hospitals, Can J Infect Dis Med Microbiol, vol.24, issue.1, pp.22-28, 2013.

G. Ranmuthugala, L. Brown, and B. A. Lidbury, Respiratory syncytial virus-the unrecognised cause of health and economic burden among young children in Australia, Commun Dis Intell Q Rep, vol.35, issue.2, pp.177-84, 2011.

R. S. Gomez, Respiratory syncytial virus: pathology, therapeutic drugs and prophylaxis, Immunol Lett, vol.162, issue.1, pp.237-284, 2014.
DOI : 10.1016/j.imlet.2014.09.006

D. Corti, Cross-neutralization of four paramyxoviruses by a human monoclonal antibody, Nature, vol.501, issue.7467, pp.439-482, 2013.

J. P. Devincenzo, Viral load drives disease in humans experimentally infected with respiratory syncytial virus, Am J Respir Crit Care Med, vol.182, issue.10, pp.1305-1319, 2010.

S. M. Bueno, Protective T cell immunity against respiratory syncytial virus is efficiently induced by recombinant BCG, Proc Natl Acad Sci, vol.105, issue.52, pp.20822-20829, 2008.
DOI : 10.1073/pnas.0806244105

URL : http://www.pnas.org/content/105/52/20822.full.pdf

T. Rothoeft, Differential response of human naive and memory/effector T cells to dendritic cells infected by respiratory syncytial virus, Clin Exp Immunol, vol.150, issue.2, pp.263-73, 2007.

P. F. Cespedes, Surface expression of the hRSV nucleoprotein impairs immunological synapse formation with T cells, Proc Natl Acad Sci, vol.111, issue.31, pp.3214-3237, 2014.

K. K. Mckinstry, Memory, vol.4

, + T cells protect against influenza through multiple synergizing mechanisms, J Clin Invest, vol.122, issue.8, pp.2847-56, 2012.

T. P. Welliver, Severe human lower respiratory tract illness caused by respiratory syncytial virus and influenza virus is characterized by the absence of pulmonary cytotoxic lymphocyte responses, J Infect Dis, vol.195, issue.8, pp.1126-1162, 2007.

M. L. Everard, Analysis of cells obtained by bronchial lavage of infants with respiratory syncytial virus infection, Arch Dis Child, vol.71, issue.5, pp.428-460, 1994.

J. E. Johnson, The histopathology of fatal untreated human respiratory syncytial virus infection, Mod Pathol, vol.20, issue.1, pp.108-127, 2007.
DOI : 10.1038/modpathol.3800725

URL : https://www.nature.com/articles/3800725.pdf

S. Z. Wang and K. D. Forsyth, The interaction of neutrophils with respiratory epithelial cells in viral infection, Respirology, vol.5, issue.1, pp.1-10, 2000.

A. M. Harrison, Respiratory syncytical virus-induced chemokine expression in the lower airways: eosinophil recruitment and degranulation, Am J Respir Crit Care Med, vol.159, issue.6, pp.1918-1942, 1999.

A. Guerrero-plata, Subversion of pulmonary dendritic cell function by paramyxovirus infections, J Immunol, vol.182, issue.5, pp.3072-83, 2009.
DOI : 10.4049/jimmunol.0802262

URL : http://www.jimmunol.org/content/182/5/3072.full.pdf

V. A. Fulginiti, Respiratory virus immunization. I. A field trial of two inactivated respiratory virus vaccines; an aqueous trivalent parainfluenza virus vaccine and an alum-precipitated respiratory syncytial virus vaccine, Am J Epidemiol, vol.89, issue.4, pp.435-483, 1969.

A. Z. Kapikian, An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine, Am J Epidemiol, vol.89, issue.4, pp.405-426, 1969.

E. M. Castilow, M. R. Olson, and S. M. Varga, Understanding respiratory syncytial virus (RSV) vaccine-enhanced disease, Immunol Res, vol.39, issue.1-3, pp.225-264, 2007.
DOI : 10.1007/s12026-007-0071-6

B. T. Srinivasa, E. D. Fixman, and B. J. Ward, Inhibition of STAT6 during vaccination with formalin-inactivated RSV prevents induction of Th2-cell-biased airway disease, Eur J Immunol, vol.44, issue.8, pp.2349-59, 2014.

M. R. Olson, S. M. Hartwig, and S. M. Varga, The number of respiratory syncytial virus (RSV)-specific memory CD8 T cells in the lung is critical for their ability to inhibit RSV vaccine-enhanced pulmonary eosinophilia, J Immunol, vol.181, issue.11, pp.7958-68, 2008.

W. W. Stevens, Pulmonary eosinophilia is attenuated by early responding CD8(+) memory T cells in a murine model of RSV vaccine-enhanced disease, Viral Immunol, vol.22, issue.4, pp.243-51, 2009.

K. M. Cautivo, Efficient lung recruitment of respiratory syncytial virusspecific Th1 cells induced by recombinant bacillus Calmette-Guerin promotes virus clearance and protects from infection, J Immunol, vol.185, issue.12, pp.7633-7678, 2010.

J. A. Espinoza, Impaired learning resulting from respiratory syncytial virus infection, Proc Natl Acad Sci, vol.110, issue.22, pp.9112-9119, 2013.
DOI : 10.1073/pnas.1217508110

URL : http://europepmc.org/articles/pmc3670318?pdf=render

K. A. Herd, Pulmonary infection of mice with human metapneumovirus induces local cytotoxic T-cell and immunoregulatory cytokine responses similar to those seen with human respiratory syncytial virus, J Gen Virol, vol.91, pp.1302-1312, 2010.

K. Bohmwald, Central nervous system alterations caused by infection with the human respiratory syncytial virus, Rev Med Virol, vol.24, issue.6, pp.407-426, 2014.
DOI : 10.1002/rmv.1813

J. I. Moliva, J. Turner, and J. B. Torrelles, Prospects in Mycobacterium bovis Bacille Calmette et Guerin (BCG) vaccine diversity and delivery: Why does BCG fail to protect against tuberculosis? Vaccine, 2015.

B. B. Trunz, P. Fine, and C. Dye, Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness, Lancet, vol.367, issue.9517, pp.1173-80, 2006.

A. Aggarwal and A. K. Dutta, Timing and dose of BCG vaccination in infants as assessed by postvaccination tuberculin sensitivity, Indian Pediatr, vol.32, issue.6, pp.635-644, 1995.

D. Kolli, Alveolar macrophages contribute to the pathogenesis of human metapneumovirus infection while protecting against respiratory syncytial virus infection, Am J Respir Cell Mol Biol, vol.51, issue.4, pp.502-517, 2014.

J. Murphy, The prolonged life-span of alveolar macrophages, Am J Respir Cell Mol Biol, vol.38, issue.4, pp.380-385, 2008.

K. J. Erb, Infection of mice with Mycobacterium bovis-Bacillus CalmetteGuerin (BCG) suppresses allergen-induced airway eosinophilia, J Exp Med, vol.187, issue.4, pp.561-570, 1998.

J. Leentjens, BCG vaccination enhances the immunogenicity of subsequent influenza vaccination in healthy volunteers: a randomized, placebo-controlled pilot study, J Infect Dis, vol.212, issue.12, pp.1930-1938, 2015.

T. Yokoi, Mycobacterium bovis Bacillus Calmette-Guerin suppresses inflammatory Th2 responses by inducing functional alteration of TSLPactivated dendritic cells, Int Immunol, vol.20, issue.10, pp.1321-1330, 2008.
DOI : 10.1093/intimm/dxn094

URL : https://academic.oup.com/intimm/article-pdf/20/10/1321/2067111/dxn094.pdf

J. Han, Responsiveness to respiratory syncytial virus in neonates is mediated through thymic stromal lymphopoietin and OX40 ligand, J Allergy Clin Immunol, vol.130, issue.5, 2012.
DOI : 10.1016/j.jaci.2012.08.033

URL : http://europepmc.org/articles/pmc3593657?pdf=render

H. C. Lee, Thymic stromal lymphopoietin is induced by respiratory syncytial virus-infected airway epithelial cells and promotes a type 2 response to infection, J Allergy Clin Immunol, vol.130, issue.5, pp.1187-96, 2012.
DOI : 10.1016/j.jaci.2012.07.031

URL : http://europepmc.org/articles/pmc4284103?pdf=render

M. M. Miazgowicz, Respiratory syncytial virus induces functional thymic stromal lymphopoietin receptor in airway epithelial cells, J Inflamm Res, vol.6, pp.53-61, 2013.